Wednesday, 19 December 2018

Advil meets Excedrin; SoftBank IPO; Fed meeting

1. Advil meets Excedrin: GlaxoSmithKline and Pfizer are combining their consumer healthcare businesses in a multibillion-dollar merger.
The two pharmaceutical giants — which own household brands like Advil and Tums — said in a statement Wednesday that the new company would have combined sales of $12.7 billion a year.
Britain's GSK (GSK) will control just over two-thirds of the joint venture, with US-based Pfizer (PFE) holding the rest.

No comments:

Post a Comment

Post your comment with your name and number

BITCOIN

Are you interested in cryptocurrency? Do you wish to have an amount of bitcoin but cannot buy?? Start mining your own bitcoin now by just br...